InvestorsHub Logo

Biobonic

05/26/20 6:13 AM

#31525 RE: pijoe #31524

Their thesis does come apart in so many places

Such as, 'the trial was allowed to continue because their would be no more administration of Multikine'.

Well that's the purpose of the trial, to determine the effect of administering Multikine.

When trial ends, and OMG the data says success!

What does the FDA say then?

Can't be approved because it's dangerous?!?!

Well why did you let the trial continue??

We read Thinking Critically (Costello) and his sidekick, Abbott over on SA...sounded good at the time...